Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Eli Lily ($LLY), one of the big dogs in diabetes treatments, will invest $140 million in a plant on its Indianapolis campus to begin making insulin-filled cartridges for the U.S. market. That work is currently done outside the U.S.
CEO John C. Lechleiter, during a live streamed press conference, termed it one of Lilly's most "significant U.S. based manufacturing investments in decade."
Maria Crowe, president of manufacturing, said construction on the 80,000 square-foot expansion is expected to be complete in 2014 and the company anticipates the plant will be validated, approved and operational in 2015. She said the work will involve about 350 construction jobs and the plant will be staffed by 100 people when its goes online. Based in Indianapolis, she pointed out the company has had manufacturing operations there during its entire 136-year history and has about 3,000 employees just in manufacturing operations in the city.
http://www.fiercepharmamanufacturin...-million-us-insulin-pen-production/2012-11-01
CEO John C. Lechleiter, during a live streamed press conference, termed it one of Lilly's most "significant U.S. based manufacturing investments in decade."
Maria Crowe, president of manufacturing, said construction on the 80,000 square-foot expansion is expected to be complete in 2014 and the company anticipates the plant will be validated, approved and operational in 2015. She said the work will involve about 350 construction jobs and the plant will be staffed by 100 people when its goes online. Based in Indianapolis, she pointed out the company has had manufacturing operations there during its entire 136-year history and has about 3,000 employees just in manufacturing operations in the city.
http://www.fiercepharmamanufacturin...-million-us-insulin-pen-production/2012-11-01